Smith & Nephew (SNN) Net Cash Flow (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Net Cash Flow of $12.0 million for Q4 2024, up 104.48% year-on-year from $5.9 million in Q1 2024, and up 104.48% on a QoQ basis from -$268.0 million in Q4 2023.
Smith & Nephew (SNN) Net Cash Flow (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Net Cash Flow for 16 consecutive years, with $12.0 million the latest figure, recorded in Q4 2024.
- Quarterly Net Cash Flow rose 104.48% year-over-year to $12.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $12.0 million (up 100.98% YoY) and the FY2025 annual result came in at -$76.0 million, down 122.89% from the prior year.
- Net Cash Flow grew to $12.0 million in Q4 2024 per SNN's latest filing, from -$268.0 million in the prior quarter.
- Over the last five years, Net Cash Flow for SNN reached as high as $12.0 million in Q4 2024 and fell as low as -$972.0 million in Q4 2022.
- A 5-year average of -$392.4 million and a median of -$268.0 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2021 — Net Cash Flow plunged 73200.0% — and 2024, when it surged 104.48%.
- Year by year, Net Cash Flow stood at -$1.0 million in 2020, then tumbled by 73200.0% to -$733.0 million in 2021, then slumped by 32.61% to -$972.0 million in 2022, then surged by 72.43% to -$268.0 million in 2023, then jumped by 104.48% to $12.0 million in 2024.
- According to Business Quant data, Net Cash Flow over the past three periods registered $12.0 million, -$268.0 million, and -$972.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 20.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12.00 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | -268.00 Mn |
| Dec 31, 2023 | -268.00 Mn |
| Dec 31, 2022 | -972.00 Mn |
| Dec 31, 2022 | -972.00 Mn |
| Dec 31, 2021 | -733.00 Mn |
| Dec 31, 2021 | -733.00 Mn |
| Dec 31, 2020 | -1.00 Mn |
| Dec 31, 2020 | -1.00 Mn |
| Dec 31, 2019 | -948.00 Mn |
| Dec 31, 2019 | -948.00 Mn |
| Dec 31, 2018 | 175.00 Mn |
| Dec 31, 2018 | 175.00 Mn |
| Dec 31, 2017 | -977.00 Mn |
| Dec 31, 2017 | -977.00 Mn |
| Dec 31, 2016 | -917.00 Mn |
| Dec 31, 2016 | -917.00 Mn |
| Dec 31, 2015 | -987.00 Mn |
| Dec 31, 2015 | -987.00 Mn |